We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
-3%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.4B
AUM Growth
-$1.17B
(-8.6%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
13.34%
Holding
358
New
14
Increased
143
Reduced
171
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$83.7M |
| 2 |
Humana
HUM
|
+$52.3M |
| 3 |
QLGC
QLOGIC CORP
QLGC
|
+$49.1M |
| 4 |
Designer Brands
DBI
|
+$45.5M |
| 5 |
Puma Biotechnology
PBYI
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$97.1M |
| 3 |
Aptiv
APTV
|
+$82.1M |
| 4 |
ATML
ATMEL CORP
ATML
|
+$66M |
| 5 |
ITMN
INTERMUNE INC
ITMN
|
+$57.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.8% |
| 2 | Technology | 18.17% |
| 3 | Healthcare | 11.61% |
| 4 | Financials | 11.28% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
BioMarin Pharmaceuticals
BMRN
$11.9B
| $5.91M | 0.05% |
81,938
-1,749
| -2% | -$115K |
|
|
TEN
277
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $5.4M | 0.04% |
103,179
-3,349
| -3% | -$213K |
|
|
MGI
278
DELISTED
MoneyGram International, Inc. New
MGI
| $5.35M | 0.04% |
426,892
-764,638
| -64% | -$10.8M |
|
|
BRCM
279
DELISTED
BROADCOM CORP CL-A
BRCM
| $5.15M | 0.04% |
127,413
+8,770
| +7% | +$341K |
|
280
TJX Companies
TJX
$179B
| $5.09M | 0.04% |
171,912
+2,060
| +1% | +$58.1K |
|
281
Perdoceo Education
PRDO
$2.17B
| $4.93M | 0.04% |
+970,373
| New | +$4.98M |
|
|
SMA
282
DELISTED
SYMMETRY MEDICAL INC
SMA
| $4.83M | 0.04% |
478,967
-2,657,786
| -85% | -$24.6M |
|
|
CVD
283
DELISTED
COVANCE INC.
CVD
| $4.68M | 0.04% |
59,468
-500,860
| -89% | -$42.5M |
|
284
KBR
KBR
$4.56B
| $4.64M | 0.04% |
246,536
-6,594
| -3% | -$143K |
|
285
Amgen
AMGN
$209B
| $4.48M | 0.04% |
31,907
+400
| +1% | +$52.2K |
|
286
Blackrock
BLK
$167B
| $4.35M | 0.04% |
13,247
+160
| +1% | +$51.5K |
|
287
UnitedHealth
UNH
$382B
| $4.23M | 0.03% |
49,062
+540
| +1% | +$45.6K |
|
288
Adtran
ADTN
$675M
| $4.22M | 0.03% |
205,502
-5,997
| -3% | -$134K |
|
289
United Parcel Service
UPS
$88.9B
| $4.22M | 0.03% |
42,910
+460
| +1% | +$45.7K |
|
|
FRM
290
DELISTED
FURMANITE CORPORATION COM
FRM
| $4.11M | 0.03% |
608,537
-760,388
| -56% | -$7.09M |
|
291
Cognizant
CTSH
$26.5B
| $3.73M | 0.03% |
83,275
+930
| +1% | +$43.8K |
|
292
American International
AIG
$42.5B
| $3.71M | 0.03% |
68,627
+780
| +1% | +$42.6K |
|
293
Gilead Sciences
GILD
$165B
| $3.59M | 0.03% |
33,746
+390
| +1% | +$38.2K |
|
294
Oracle
ORCL
$339B
| $3.54M | 0.03% |
92,601
+1,110
| +1% | +$44.9K |
|
295
Chubb
CB
$140B
| $3.54M | 0.03% |
33,704
+390
| +1% | +$40.7K |
|
296
JPMorgan Chase
JPM
$916B
| $3.52M | 0.03% |
58,480
+760
| +1% | +$44.4K |
|
|
MDR
297
DELISTED
McDermott International
MDR
| $3.51M | 0.03% |
204,570
-42,567
| -17% | -$918K |
|
298
CME Group
CME
$95.4B
| $3.36M | 0.03% |
42,050
+490
| +1% | +$36.9K |
|
299
Qualcomm
QCOM
$164B
| $3.35M | 0.03% |
44,750
+560
| +1% | +$42.8K |
|
|
KITE
300
DELISTED
Kite Pharma, Inc.
KITE
| $3.33M | 0.03% |
116,775
+32,815
| +39% | +$812K |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Frontier Capital Management held 358 positions worth $12.4B, down 8.6% from $13.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management withdrew a net $425M in Q3 2014, closing 11 positions and reducing 171 holdings. Its most notable exit was INTERMUNE INC, an estimated $57.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Humana worth $53.6M.
- Frontier Capital Management's largest Q3 2014 buy was Humana: 411,770 shares worth $53.6M.
- Frontier Capital Management added most to Centene in Q3 2014, an estimated $83.7M increase.
- Frontier Capital Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $104M.
- Frontier Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $57.5M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.4B portfolio in Q3 2014.
- Frontier Capital Management opened 14 new positions and closed 11 in Q3 2014.
- Frontier Capital Management's portfolio value fell 8.6% quarter-over-quarter to $12.4B.
Based on Frontier Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.